Top Markets
Coin of the day
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
Rang în acțiuni #5856
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Preț acțiune
$18.40
Capitalizare de piață
$2.38B
Schimbare (1 zi)
-0.22%
Schimbare (1 an)
-
Țară
US
Tranzacționează Kailera Therapeutics, Inc. (KLRA)

Categorie

Raport P/B pentru Kailera Therapeutics, Inc. (KLRA)
Raport P/B la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor Kailera Therapeutics, Inc., raportul P/B actual (TTM) este 0. La sfârșitul anului 2026, compania avea un P/B de 0.
Istoricul raportului P/B pentru Kailera Therapeutics, Inc. din 2026 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
Nu sunt suficiente date pentru perioada selectată.
Raport P/B pentru companii similare sau competitoare
Companie Raport P/B Diferență raport P/B Țara
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH